Effect of adjunct metformin treatment in patients with type-1 diabetes and persistent inadequate glycaemic control. A randomized study (Q33375701)

26 July 2017

Effect of adjunct metformin treatment in patients with type-1 diabetes and persistent inadequate glycaemic control. A randomized study (English)

1 reference

26 July 2017

0 references

1 reference

10

Peter Rossing

0 references

Lise Tarnow

object named as

Lise Tarnow

2

0 references

Hans-Henrik Parving

11

object named as

Hans-Henrik Parving

1 reference

26 July 2017

3

Anne Sofie Astrup

1 reference

26 July 2017

8

Lotte Pietraszek

1 reference

26 July 2017

4

Peter Hovind

1 reference

26 July 2017

5

Peter Karl Jacobsen

1 reference

26 July 2017

Søren Søgaard Lund

1

1 reference

26 July 2017

Amra Ciric Alibegovic

6

1 reference

26 July 2017

Ida Parving

7

1 reference

26 July 2017

Merete Frandsen

9

1 reference

26 July 2017

Allan Arthur Vaag

12

1 reference

26 July 2017

language of work or name

English

0 references

publication date

9 October 2008

1 reference

26 July 2017

1 reference

26 July 2017

3

1 reference

26 July 2017

e3363

1 reference

26 July 2017

10

1 reference

Creative Commons Attribution 4.0 International

26 July 2017

start time

9 October 2008

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

The addition of metformin in type 1 diabetes improves insulin sensitivity, diabetic control, body composition and patient well-being

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2566605

Standards of medical care in diabetes--2006

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2566605

Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 Diabetes

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2566605

Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2566605

Metformin monotherapy for type 2 diabetes mellitus

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2566605

Persistent poor glycaemic control in adult Type 1 diabetes. A closer look at the problem

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2566605

Body-Mass Index and Mortality in a Prospective Cohort of U.S. Adults

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2566605

Guidelines for healthy weight

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2566605

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2566605

What's wrong with Bonferroni adjustments

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2566605

Hyperinsulinemia as an independent risk factor for ischemic heart disease.

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2566605

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2566605

Effects of metformin on haemorheology, lipid parameters and insulin resistance in insulin-dependent diabetic patients (IDDM)

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2566605

Hepatic and peripheral insulin resistance: a common feature of type 2 (non-insulin-dependent) and type 1 (insulin-dependent) diabetes mellitus.

14 July 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0003363

Metformin: new understandings, new uses

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0003363

Metformin adjunctive therapy with insulin improves glycemic control in patients with type 1 diabetes mellitus: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0003363

The benefits of metformin therapy during continuous subcutaneous insulin infusion treatment of type 1 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0003363

Metformin as additional therapy in adolescents with poorly controlled type 1 diabetes: randomised placebo-controlled trial with aspects on insulin sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0003363

Metformin as an adjunct therapy in adolescents with type 1 diabetes and insulin resistance: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0003363

The effect of metformin on blood glucose control in overweight patients with Type 1 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0003363

Efficacy of metformin in type II diabetes: results of a double-blind, placebo-controlled, dose-response trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0003363

Targeting hyperglycaemia with either metformin or repaglinide in non-obese patients with type 2 diabetes: results from a randomized crossover trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0003363

Metformin in the treatment of type 1 diabetics--a placebo controlled study

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2566605

Studies on juvenile--type diabetes in children. Assessment of control under treatment with constant and variable doses of insulin with or without addition of biguanides

31 October 2018

1 reference

12 December 2020

Metformin reduces post-prandial insulin needs in type I (insulin-dependent) diabetic patients: Assessment by the artificial pancreas

1 reference

12 December 2020

Metformin reduces insulin requirement in Type 1 (insulin-dependent) diabetes

1 reference

12 December 2020

Metformin improved insulin resistance in type I, insulin-dependent, diabetic patients

1 reference

12 December 2020

Study of the effect of metformin on platelet aggregation in insulin-dependent diabetics

1 reference

12 December 2020

Dimethyldiguanide in the treatment of diabetic children

1 reference

12 December 2020

Study of the action of a biguanide (N,N-dimethylguanylguanidine) on a group of 235 diabetic children

1 reference

12 December 2020

10.1371/JOURNAL.PONE.0003363

Identifiers

DOI

1 reference

26 July 2017

0 references

1 reference

26 July 2017

1 reference